Andrew Gentles
Stanford University
H-index: 52
North America-United States
Top articles of Andrew Gentles
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Cell-free RNA analysis for non-invasive cancer detection and characterization | Cancer Research | Monica C Nesselbush Bogdan A Luca Young-Jun Jeon Isabel Jabara Catherine B Meador | 2024/3/22 |
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity | Research Square | Matthew Schwede Katharina Jahn Jack Kuipers Linde A Miles Robert L Bowman | 2023/11/6 |
Endometrioid Endometrial RNA Index Predicts Recurrence in Stage I Patients | Clinical Cancer Research | Corrine A Nief Phoebe M Hammer Aihui Wang Vivek Charu Amina Tanweer | 2024/4/26 |
Multimodal data fusion for cancer biomarker discovery with deep learning | Sandra Steyaert Marija Pizurica Divya Nagaraj Priya Khandelwal Tina Hernandez-Boussard | 2023/4 | |
Translatome analysis reveals microglia and astrocytes to be distinct regulators of inflammation in the hyperacute and acute phases after stroke | Glia | Victoria G Hernandez Kendra J Lechtenberg Todd C Peterson Li Zhu Tawaun A Lucas | 2023/8 |
Profiling Cellular Ecosystems at Single-Cell Resolution and at Scale with EcoTyper | Chloé B Steen Bogdan A Luca Ash A Alizadeh Andrew J Gentles Aaron M Newman | 2023/3/17 | |
Determinants of response to T‐cell stimulation by CD27 antibody therapy in lymphoma: The RiVa trial | Hematological Oncology | MJ Rose‐Zerilli L Buermann L Stanton CM Wignall AR Coleman | 2023/6 |
Systems and Methods for Deconvoluting Tumor Ecosystems for Personalized Cancer Therapy | 2023/1/26 | ||
Abstract A49: Characterizing the order of mutation acquisition in acute myeloid leukemia using large-scale single-cell sequencing | Blood Cancer Discovery | Matthew Schwede Katharina Jahn Linde A Miles Robert L Bowman Jack Kuipers | 2023/5/1 |
Accelerating Immune Reconstitution in HSCT Patients through iPSC-Derived Thymic Epithelial Cells | Blood | Abdulvasey Mohammed Hanh Dan Nguyen Kelsea Hubka Wenqing Wang Phd Priscila Slepicka | 2023/11/28 |
Single-cell genomics in AML: extending the frontiers of AML research | Asiri Ediriwickrema Andrew J Gentles Ravindra Majeti | 2023/1/26 | |
Abstract A52: IDS and SETBP1 is highly prognostic in myelodysplastic neoplasms and is a candidate stem cell signature | Blood Cancer Discovery | Asiri Ediriwickrema Andrew Gentles Ravindra Majeti | 2023/5/1 |
Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer | Genome Medicine | Kevin Brennan Almudena Espín-Pérez Serena Chang Nikita Bedi Saumyaa Saumyaa | 2023/11/17 |
Abstract PR013: Lymph node colonization promotes distant tumor metastasis through the induction of tumor-specific immune tolerance | Cancer Research | Nathan E Reticker-Flynn Weiruo Zhang Julia A Belk Pamela A Basto Andrew J Gentles | 2023/1/15 |
Lymph node colonization promotes distant tumor metastasis through the induction of tumor-specific immune tolerance | Cancer Research | Nathan E Reticker-Flynn Weiruo Zhang Julia A Belk Pamela A Basto Andrew J Gentles | 2023/4/4 |
High-resolution alignment of single-cell and spatial transcriptomes with CytoSPACE | Nature biotechnology | Milad R Vahid Erin L Brown Chloé B Steen Wubing Zhang Hyun Soo Jeon | 2023/11 |
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML | bioRxiv | Ece Canan Sayitoglu Bogdan A Luca Allison P Boss Benjamin Canan Thomas Robert A Freeborn | 2023 |
Abstract PR05: Lymph node colonization promotes distant tumor metastasis through the induction of tumor-specific immune tolerance | Cancer Immunology Research | Nathan E Reticker-Flynn Weiruo Zhang Julia A Belk Andrew J Gentles Ansuman Satpathy | 2022/1/1 |
Community assessment of methods to deconvolve cellular composition from bulk gene expression | bioRxiv | Brian S White Aurélien de Reyniès Aaron M Newman Joshua J Waterfall Andrew Lamb | 2022/6/5 |
1477 First efficacy and multi-omic analysis data from phase 1 clinical trial of oncolytic viral immunotherapy with CAN-2409+ valacyclovir in combination with nivolumab and … | Patrick Wen Caroline Duault Edgar Gonzalez-Kozlova Kevin Brennan Tyson Holmes | 2022/11/1 |
Co-Authors
